Molecular Partners

Molecular Partners is a clinical-stage biotechnology company developing DARPin therapeutics, a class of engineered protein drugs designed for multi-target and multifunctional applications. Its pipeline focuses mainly on oncology, including targeted radiopharmaceuticals and next-generation immune-cell engagers, with programs advanced internally and through partnerships.

Relationship details are part of the Pro plan.